Form 4: Medtronic CEO Sells Shares to Cover Taxes on Vested Stock

Medtronic's CEO, Geoffrey Martha, sold 4,417 shares to cover taxes upon the vesting of restricted stock units.

Summary

• Medtronic CEO Geoffrey Martha sold 4,417 ordinary shares on December 16, 2024, at a price of $82.48 per share.
• The sale was to cover tax obligations arising from the vesting of restricted stock units.
• Following the transaction, Martha directly owns 181,326 ordinary shares.
• This total includes 829 shares acquired through dividend reinvestment since the last report.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax liabilities when stock options or restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover taxes are a common practice across publicly traded companies.
• The number of shares sold is relatively small compared to the total holdings of the CEO, suggesting this is a routine tax-related transaction rather than a significant divestment.
• Other CEOs in the medical device industry also regularly file Form 4s for similar transactions.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

Medtronic, CEO, Geoffrey Martha, stock sale, Form 4, insider trading, restricted stock units, tax obligations, dividend reinvestment